Skip to main content

Biotech Bloodbath: Hedge Fund Hotel Sarepta Collapses After Study Disappoints

Sarepta, the hedge-fund-hotel has done it again, collapsing over 50% after hours following reports that a key study from the industry leader missed lofty investor expectations.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.